A carregar...

Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer

Basal-like breast cancer is an aggressive disease with limited therapeutic options because these tumors frequently express the ‘triple-negative’ phenotype. We have recently reported that inducible nitric oxide synthase (NOS2) is a strong predictor of survival in patients with estrogen receptor negat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Switzer, Christopher H., Glynn, Sharon A., Ridnour, Lisa A., Cheng, Robert Y.-S., Vitek, Michael P., Ambs, Stefan, Wink, David A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3380363/
https://ncbi.nlm.nih.gov/pubmed/21893353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2011.07.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!